MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma

Federica Grosso, Luigi Cerbone, Alessandra Curioni-Fontecedro

Open source

DOI
10.1016/s2213-2600(24)00146-2
Published
2024-06
Container
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-24-00146-2,
  title = {MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma},
  author = {Federica Grosso and Luigi Cerbone and Alessandra Curioni-Fontecedro},
  year = {2024},
  journal = {The Lancet Respiratory Medicine},
  doi = {10.1016/s2213-2600(24)00146-2},
  url = {https://doi.org/10.1016/s2213-2600(24)00146-2}
}

RIS

TY  - JOUR
TI  - MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma
AU  - Federica Grosso
AU  - Luigi Cerbone
AU  - Alessandra Curioni-Fontecedro
PY  - 2024
JO  - The Lancet Respiratory Medicine
DO  - 10.1016/s2213-2600(24)00146-2
UR  - https://doi.org/10.1016/s2213-2600(24)00146-2
ER  - 

APA

Grosso, F., Cerbone, L., & Curioni-Fontecedro, A. (2024). MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(24)00146-2

Source records